Making sense of the Peralta deal

From Biogenesis to big deal . . .

From Biogenesis to big deal . . .

So what to make of the Jhonny Peralta signing with the St. Louis Cardinals, in the wake of his having been one of the Biogenesis 13? Among other things:

1) A four year deal at $52 million dollars isn’t exactly what anyone expected to see for a player bagged over actual or alleged performance-enhancing substances. Without that issue, however, it’s a questionable deal considering Peralta’s age (32), his faltering defensive range, and his batting average-dependent on-base percentage.